Overview
Switching from one GLP-1 weight-loss medication to another, such as Mounjaro® or Wegovy®, can feel unsettling when your current treatment is already working. MedExpress provides clinical oversight and ongoing monitoring throughout your GLP-1 switch to help keep the transition smooth and safe.
Use this article when you want to:
Understand the clinical oversight you receive when switching GLP-1 medications with MedExpress
Find out what monitoring you'll get during your first month on your new GLP-1 medication
Learn how MedExpress supports you in managing your treatment plan with confidence after switching GLP-1 medications
What Clinical Oversight Do I Get When Switching GLP-1 Medications?
When you switch GLP-1 medications with MedExpress (for example, from Mounjaro® to Wegovy®, or to Foundayo®), you aren't just changing a prescription: you receive guided clinical care throughout the transition:
Tailored starting dose: a MedExpress clinician reviews your medical history and current GLP-1 treatment to select the most appropriate starting dose for your new medication.
Monitoring: MedExpress provides ongoing check-ins during your first month on your new GLP-1 medication, to make sure your body is adjusting well to the change.
Dose adjustments if needed: if you experience side effects during these check-ins, your MedExpress prescriber can adjust your treatment plan as part of the review.
How Do I Manage the Change After Switching GLP-1 Medications?
Transitioning to a new GLP-1 medication, such as Wegovy®, is a process designed to help you maintain your weight loss progress.
By following your MedExpress clinical team's guidance and sticking to your new GLP-1 treatment schedule, you can continue your weight loss journey with minimal disruption.